science

The International Pharmacopoeia

The International Pharmacopoeia is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand The International Pharmacopoeia rather than just read about it. In short: The International Pharmacopoeia (Pharmacopoeia Internationalis, or Ph. Int.) is a pharmacopoeia issued by the World Health Organization as a recommendation, with the aim to provide international quality specifications for pharmaceutical substances (active ingredients and excipients) and dosage forms, together with supporting general methods of analysis, for global use.

Key takeaways

The International Pharmacopoeia belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect The International Pharmacopoeia to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of The International Pharmacopoeia from memory before moving on to harder problems.

Reference excerpt

The International Pharmacopoeia (Pharmacopoeia Internationalis, or Ph. Int.) is a pharmacopoeia issued by the World Health Organization as a recommendation, with the aim to provide international quality specifications for pharmaceutical substances (active ingredients and excipients) and dosage forms, together with supporting general methods of analysis, for global use. Its texts can be used or adapted by any WHO member state wishing to establish legal pharmaceutical requirements.

Contents The Ph.Int. is based primarily on medicines included in the current WHO Model List of Essential Medicines (EML) and medicines included in the current invitations to manufacturers to submit an expression of interest (EOI) to the WHO Prequalification Team – Medicines (PQT) and those of interest to other UN Organizations. In recent years, priority has been given to medicines of importance in low and middle income countries, which may not appear in any other pharmacopoeias, including child-friendly dosage forms. The Ph.Int. is designed to serve all Member States, especially their national and regional regulatory authorities, organizations in the United Nations system, and regional and interregional harmonization efforts, and they underpin important public health initiatives, including the prequalification and procurement of quality medicines through major international entities, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, and UNICEF. The monographs published in the Ph.Int. are established in an independent manner via a consultative procedure and based on international experience. Monographs on radiopharmaceuticals developed with the International Atomic Energy Agency.

History

Early history

The first international pharmaceutical congress was held in Strasbourg in 1867, and emitted the wish that an international pharmacopoeia be compiled. The "Conference for the Unification of the Formulae of Potent Medicaments" held in Brussels in 1902 was also the 10th pharmacists' congress. It resulted in a treaty considered as the start of the international pharmacopoeial project although "it took four years of textual adjustments before the Agreement could enter into force as a multilateral treaty in 19 (mostly European) countries, in December 1906" A second conference met in Brussels' Academy Palace in 1925, resulting in the revised 1925 Brussels Pharmacopoeia Agreement. After the Second World War, the World Health Organization took over the Brussels Agreement and its secretariat hosted by the League of Nations, and subsequently discontinued and replaced the 1925 Brussels Agreement with the International Pharmacopoeia edited since 1951.

Editions

See also Pharmacopoeia First International Pharmacopoeia Agreement (Brussels, 1902) and Second Agreement (Brussels, 1925) European Pharmacopoeia, another supranational pharmacopoeia Compounding Monograph Pharmaceutical formulation Global health World Health Organization

References

External links Official website Procedure for the development of monographs and other texts for The International Pharmacopoeia. WHO Technical Report Series No. 992, 2015, Annex 1. The International Pharmacopoeia: revised concepts and future perspectives. WHO Technical Report Series, No. 908, 2003, Annex 2. Current projects: Monographs and general tests under review/revision for inclusion in the International Pharmacopoeia Radiopharmaceuticals Updating mechanism for the section on radiopharmaceuticals in The International Pharmacopoeia. WHO Technical Report Series, No. 992, 2015, Annex 2. Trade names of stationary phases found suitable in performing chromatographic tests described in The International Pharmacopoeia. Omitted Monographs WHO Expert Committee on Specifications for Pharmaceutical Preparations

Illustrations

Worked examples

Example 1 — a first encounter with The International Pharmacopoeia

Start with the simplest possible case. Write down what The International Pharmacopoeia claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to The International Pharmacopoeia before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about The International Pharmacopoeia ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of The International Pharmacopoeia

In research: The International Pharmacopoeia appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses The International Pharmacopoeia in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: The International Pharmacopoeia is common in secondary-school and first-year university syllabi. It links to neighbouring topics Pharmacopoeias, so understanding it makes those chapters shorter.
In everyday life: Look for The International Pharmacopoeia outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “The International Pharmacopoeia” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study The International Pharmacopoeia in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what The International Pharmacopoeia means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain The International Pharmacopoeia out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is The International Pharmacopoeia in simple terms?

Why does The International Pharmacopoeia matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study The International Pharmacopoeia?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on The International Pharmacopoeia.